- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04251936
Modification of Alternative Reward Cue Reactivity and Cognitive Control Through Physical Activity in Human Tobacco Use Disorder
January 10, 2024 updated by: Prof. Dr. Andreas Ströhle, Charite University, Berlin, Germany
This study investigates the mechanisms, through which physical exercise impacts positively on abstinence in tobacco use disorder, with fMRI and behavioral tests.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will test the hypothesis that physical exercise training modifies alternative reward cue reactivity and cognitive control in tobacco use disorder and that these modifications mediate the effect of exercise on abstinence.
Continued physical exercise training was shown to reduce tobacco consumption and prevent relapse in tobacco use disorder (TUD).
However, the psychological and neural mechanisms through which exercise training exerts its effects on tobacco consumption are not clear.
The aim of this project is to identify the effects of a 12-week aerobic exercise training in TUD and to test how these exercise-related changes may mediate the effect of exercise training on abstinence.
Investigations will focus on two potential mechanisms of regaining control: (1) modifications of tobacco and alternative reward cue reactivity and (2) improvement of cognitive control.
Two aspects of cognitive control will be addressed: inhibitory control and cognitive down-regulation of craving.
It is expected, first, that exercise training (compared to standard treatment) leads to desensitization towards tobacco cues and sensitization towards alternative reward cues, reflected in altered craving and neural (fMRI) cue reactivity.
Second, it is expected that exercise training will lead to increased cognitive control (i.e., inhibitory control and cognitive down-regulation of craving), reflected in increased activation of prefrontal control regions (fMRI).
Third, it is expected that effects of exercise on abstinence will be mediated by sensitization towards alternative reward cues and enhanced cognitive control.
In an exploratory manner, gender differences in the effects of exercise training will be studied.
Understanding the psychological and neural underpinnings will help to optimize and individualize exercise trainings in TUD.
Study Type
Interventional
Enrollment (Actual)
82
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10117
- Charité Universitätsmedizin Berlin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Tobacco use disorder according to DSM-5
- right-handedness
- sufficient ability to communicate with investigators
- ability to provide informed consent and to use self-rating scales
- seeking treatment for TUD
- no contra-indication for aerobic exercise
Exclusion Criteria:
- severe internal or neurological comorbidities
- axis I mental disorders other than TUD (except for mild depression, adjustment disorder and specific phobias) in the last 12 months according to DSM-5
- history of brain injury
- pregnancy
- exclusion criteria for MRI
- positive drug screening (opioids, benzodiazepines, cocaine, amphetamines)
- psychotropic medication within the last 14 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise training plus smoking cessation group program
|
The moderate-intense aerobic exercise training will involve supervised aerobicycle ergometer training for 30 min with 60-80% HRmax three times per week for 12 weeks.
Participants of both groups will receive a 6-week standard cognitive behavioral therapy-oriented smoking cessation group program (SCP, one 60 min session per week).
|
Active Comparator: Smoking cessation group program
|
Participants of both groups will receive a 6-week standard cognitive behavioral therapy-oriented smoking cessation group program (SCP, one 60 min session per week).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in nicotine consumption from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
self-report
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Change in nicotine consumption from pre-intervention to follow-up
Time Frame: Pre-intervention and follow-up (12 weeks after intervention end)
|
self-report
|
Pre-intervention and follow-up (12 weeks after intervention end)
|
Change in BOLD during cue reactivity task (fMRI) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Blood Oxygen Level Dependent especially within the ventral striatum, the ventral medial prefrontal cortex and the amygdala during a cue reactivity task with neutral, tobacco, alternative reward images and warning images depicting aversive consequences of smoking
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Change in BOLD during down-regulation of craving task (fMRI) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Blood Oxygen Level Dependent especially within the ventral striatum, the amygdala and the dorsolateral prefrontal cortex during a cognitive down-regulation of craving task with tobacco and alternative reward stimuli
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Change in BOLD during stop-signal task (fMRI) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Blood Oxygen Level Dependent especially within the dorsolateral prefrontal cortex during a stop signal task
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Change in craving ratings (behavioral) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
The participants' answers to the question "how strong is your desire to consume the item shown" on a scale of 1 - 8 is averaged over a total of 144 pictures of nicotine and alternative reward stimuli.
The change in average ratings between pre-intervention and post-intervention is computed.
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Change in down-regulation of craving (behavioral) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
The down-regulation of craving task is carried out as described in Kober et al., 2010.
As described there, the down-regulation of craving is calculated as the difference in craving ratings between the now and later condition (20 nicotine and alternative reward stimuli are shown in the now and later condition).
The change in the down-regulation of craving between pre- and post-intervention is then calculated.
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Change in stop-signal reaction time (behavioral) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Stop-signal reaction time in the stop-signal task
|
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14811-6. doi: 10.1073/pnas.1007779107. Epub 2010 Aug 2.
- Kunas SL, Stuke H, Plank IS, Laing EM, Bermpohl F, Strohle A. Neurofunctional alterations of cognitive down-regulation of craving in quitting motivated smokers. Psychol Addict Behav. 2022 Dec;36(8):1012-1022. doi: 10.1037/adb0000820. Epub 2022 Feb 17.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2020
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
June 30, 2023
Study Registration Dates
First Submitted
January 16, 2020
First Submitted That Met QC Criteria
January 30, 2020
First Posted (Actual)
February 5, 2020
Study Record Updates
Last Update Posted (Actual)
January 12, 2024
Last Update Submitted That Met QC Criteria
January 10, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRR265 C03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Exercise training
-
University of British ColumbiaMichael Smith Foundation for Health ResearchCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Universidade Norte do ParanáCompleted
-
University of Colorado, DenverVA Eastern Colorado Health Care SystemCompletedHealthy | Overweight | Type 2 Diabetes Mellitus | Cardiovascular Risk FactorUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Universita di VeronaRecruiting
-
University of LeipzigCompletedImpact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CADStable Coronary Artery DiseaseGermany
-
Helse Stavanger HFStavanger Health ResearchCompletedVentricular TachycardiaNorway
-
Hacettepe UniversityCompleted